Treatments and outcomes in ulcerative colitis
Part of Digestive system clinical trials.
This study looks at how different treatments work for ulcerative colitis and tracks what happens to patients over time. It could help doctors find better ways to manage the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with ulcerative colitis by a doctor.
- You have received care for ulcerative colitis at a participating medical center during the study period.
- You have enough medical records to confirm your diagnosis and track your condition over time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares three types of medications (vedolizumab, ustekinumab, and JAK inhibitors) in people with ulcerative colitis who have already tried an anti-TNF drug but still have active disease. The goal is to see which treatment works best as a second option.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
This trial studies people with ulcerative colitis who are in a 'remission-recurrence' state, meaning their symptoms come and go. It aims to better understand this pattern and may help guide future treatments.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.
This study tests whether monitoring ulcerative colitis with stool-based markers—simple, non-invasive tests—can help guide treatment as effectively as the usual care approach. It aims to see if this strategy helps you stay in remission and avoid flare-ups.
Hear when a new Ulcerative Colitis (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.